Oxolamine

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C14H19N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 90BEA145GY, chemically known as 1,2,4-oxadiazole, 5-(2-(diethylamino)ethyl)-3-phenyl- but generally known as oxolamine, which bears US NIH Compound Identifier 13738. European Medicines Agency schedules Oxolamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09547MIG. The term OXOLAMINE is an International Non-Proprietary Name. World Health Organization schedules oxolamine in its Anatomical Therapeutic Chemical (ATC) Classification. OXOLAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxolamine under HS 29349990 and SITC 51579. As of Q4 2014, OXOLAMINE remains the US FDA Preferred Term for this commodity. Oxolamine bears US NLM identifiers UMLS ID C0069787 and NCI Concept Code C66274. SMILES: O1NC(NC1CCN(CC)CC)C1CCCCC1.